IFA
Invus Financial Advisors Portfolio holdings
AUM
$89.2M
This Quarter Return
+28.85%
1 Year Return
-10.79%
3 Year Return
-29.46%
5 Year Return
–
10 Year Return
–
AUM
$239M
AUM Growth
+$239M
(+15%)
Cap. Flow
-$12.8M
Cap. Flow
% of AUM
-5.36%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Yext
YEXT
|
$12.8M |
| 2 |
Oric Pharmaceuticals
ORIC
|
$34 |
Sector Composition
| 1 | Healthcare | 83.8% |
| 2 | Technology | 16.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
NovoCure
NVCR
$1.38B
| $60.7M | 25.38% |
350,884
| – | – |
|
|
OYST
2
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $52.1M | 21.78% |
2,768,586
| – | – |
|
3
Arcus Biosciences
RCUS
$1.13B
| $47.8M | 19.99% |
1,842,077
| – | – |
|
|
4
Yext
YEXT
$1.11B
| $38.8M | 16.2% |
2,465,308
-815,577
| -25% | -$12.8M |
|
|
5
Oric Pharmaceuticals
ORIC
$994M
| $34.1M | 14.26% |
1,007,575
-1
| -0% | -$34 |
|
|
UBX
6
DELISTED
Unity Biotechnology
UBX
| $5.74M | 2.4% |
1,094,998
| – | – |
|